Biotoxtech

086040 · KOSDAQ · ₩086040 · 바이오톡스텍

₩2,110▲ ₩30 (1.44%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩47B₩41B₩33B₩37B₩34B
Cost of sales₩41B₩39B₩31B₩25B₩22B
Gross profit₩5.9B₩2.6B₩1.9B₩12B₩12B
Operating income−₩4.8B−₩8.9B−₩8.2B₩800M₩4.2B
Net income−₩1.6B−₩13B−₩9B₩1.5B₩7B
Net income to shareholders₩1.2B−₩6.4B−₩4.9B₩2.7B₩7.1B

Balance sheet

20252024202320222021
Total assets₩132B₩136B₩147B₩126B₩91B
Current assets₩49B₩59B₩65B₩49B₩38B
Cash and equivalents₩19B₩11B₩27B₩13B₩19B
Total liabilities₩100B₩102B₩99B₩81B₩49B
Current liabilities₩85B₩82B₩75B₩60B₩46B
Borrowings₩38B₩42B₩44B₩35B₩27B
Total equity₩32B₩35B₩48B₩44B₩42B
Shareholders' equity₩40B₩40B₩52B₩44B₩41B

Cash flow

20252024202320222021
Cash from operations₩6.6B−₩7.1B−₩16B−₩1.3B₩4.3B
Capital spending₩2.1B₩2B₩4.5B₩31B₩7.6B
Free cash flow₩4.5B−₩9.1B−₩21B−₩32B−₩3.3B

Consolidated where available. Amounts in won.

Also known as: Biotoxtech / 바이오톡스텍 / 086040 / KRX:086040

Source: KRX statistical information